FI20115670A0 - Kardiovaskulaarinen in vitro-malli - Google Patents
Kardiovaskulaarinen in vitro-malliInfo
- Publication number
- FI20115670A0 FI20115670A0 FI20115670A FI20115670A FI20115670A0 FI 20115670 A0 FI20115670 A0 FI 20115670A0 FI 20115670 A FI20115670 A FI 20115670A FI 20115670 A FI20115670 A FI 20115670A FI 20115670 A0 FI20115670 A0 FI 20115670A0
- Authority
- FI
- Finland
- Prior art keywords
- cardiovascular model
- relates
- model
- platform
- vitro
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1382—Adipose-derived stem cells [ADSC], adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20115670A FI20115670A0 (fi) | 2011-06-23 | 2011-06-23 | Kardiovaskulaarinen in vitro-malli |
BR112013033246A BR112013033246A2 (pt) | 2011-06-23 | 2012-06-14 | modelo cardiovascular in vitro |
CN201280030909.0A CN103814124A (zh) | 2011-06-23 | 2012-06-14 | 体外心血管模型 |
DK12803040.0T DK2723853T3 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
US14/128,766 US20140206029A1 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
CA2839052A CA2839052A1 (fr) | 2011-06-23 | 2012-06-14 | Modele cardiovasculaire in vitro |
KR1020147000113A KR20140048190A (ko) | 2011-06-23 | 2012-06-14 | 시험관내 심혈관 모델 |
EP12803040.0A EP2723853B1 (fr) | 2011-06-23 | 2012-06-14 | Modèle cardiovasculaire in vitro |
JP2014516404A JP2014519837A (ja) | 2011-06-23 | 2012-06-14 | インビトロの心臓血管モデル |
PCT/FI2012/050611 WO2012175797A1 (fr) | 2011-06-23 | 2012-06-14 | Modèle cardiovasculaire in vitro |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20115670A FI20115670A0 (fi) | 2011-06-23 | 2011-06-23 | Kardiovaskulaarinen in vitro-malli |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20115670A0 true FI20115670A0 (fi) | 2011-06-23 |
Family
ID=44206878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20115670A FI20115670A0 (fi) | 2011-06-23 | 2011-06-23 | Kardiovaskulaarinen in vitro-malli |
Country Status (10)
Country | Link |
---|---|
US (1) | US20140206029A1 (fr) |
EP (1) | EP2723853B1 (fr) |
JP (1) | JP2014519837A (fr) |
KR (1) | KR20140048190A (fr) |
CN (1) | CN103814124A (fr) |
BR (1) | BR112013033246A2 (fr) |
CA (1) | CA2839052A1 (fr) |
DK (1) | DK2723853T3 (fr) |
FI (1) | FI20115670A0 (fr) |
WO (1) | WO2012175797A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940997A (zh) * | 2014-03-27 | 2015-09-30 | 复旦大学 | 一种组织工程化人类心肌组织 |
CN105838670A (zh) * | 2015-01-13 | 2016-08-10 | 上海交通大学医学院附属第九人民医院 | 一种细胞混合物及其制备方法和用途 |
US20190017029A1 (en) * | 2016-02-25 | 2019-01-17 | The J. David Gladstone Institutes, a testament trust established under the Will of J. David | Generation of Expandable Cardiovascular Progenitor Cells |
CN105911096B (zh) * | 2016-03-29 | 2018-07-10 | 南京艾尔普再生医学科技有限公司 | 一种可以体外进行药物药理毒理筛查的人工心脏系统 |
IT201800007946A1 (it) * | 2018-08-07 | 2020-02-07 | 1Lab Sa | Modello per simulare in-vitro il comportamento di vasi disfunzionali |
WO2020203369A1 (fr) * | 2019-04-01 | 2020-10-08 | 凸版印刷株式会社 | Construction cellulaire et procédé de production de construction cellulaire |
CN111793609B (zh) * | 2020-09-08 | 2020-12-29 | 北京达熙生物科技有限公司 | 一种促进脂肪干细胞增殖和分化的方法 |
JPWO2022113540A1 (fr) * | 2020-11-26 | 2022-06-02 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7029838B2 (en) * | 2001-03-30 | 2006-04-18 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized contructs for implantation to provide blood perfusion |
US7052829B2 (en) * | 2001-03-30 | 2006-05-30 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized constructs for implantation to provide blood perfusion |
US20050250202A1 (en) * | 2002-03-19 | 2005-11-10 | March Keith L | Adipose stromal stem cells for tissue and vascular modification |
FR2859381B1 (fr) * | 2003-09-05 | 2008-07-25 | Centre Nat Rech Scient | Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel |
RU2334793C1 (ru) * | 2007-02-20 | 2008-09-27 | Федеральное Государственное Учреждение "Российский кардиологический научно-производственный комплекс Федерального агентства по здравоохранению и социальному развитию" | Способ получения культуры клеток с индуцированным ангиогенным фенотипом, предназначенной для тканевой инженерии в зоне ишемии |
ES2325715B1 (es) * | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
US20090169521A1 (en) | 2007-12-31 | 2009-07-02 | Technion Research & Development Foundation Ltd. | Vascularized cardiac tissue and methods of producing and using same |
US20100035297A1 (en) * | 2008-08-08 | 2010-02-11 | Indiana University Research And Technology Corporation | Methods and compositions for vasculogenic potential determination |
US8727965B2 (en) * | 2010-03-05 | 2014-05-20 | Tissue Genesis, Inc. | Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells |
-
2011
- 2011-06-23 FI FI20115670A patent/FI20115670A0/fi not_active Application Discontinuation
-
2012
- 2012-06-14 DK DK12803040.0T patent/DK2723853T3/en active
- 2012-06-14 BR BR112013033246A patent/BR112013033246A2/pt not_active IP Right Cessation
- 2012-06-14 CN CN201280030909.0A patent/CN103814124A/zh active Pending
- 2012-06-14 CA CA2839052A patent/CA2839052A1/fr not_active Abandoned
- 2012-06-14 EP EP12803040.0A patent/EP2723853B1/fr not_active Not-in-force
- 2012-06-14 US US14/128,766 patent/US20140206029A1/en not_active Abandoned
- 2012-06-14 JP JP2014516404A patent/JP2014519837A/ja active Pending
- 2012-06-14 KR KR1020147000113A patent/KR20140048190A/ko not_active Application Discontinuation
- 2012-06-14 WO PCT/FI2012/050611 patent/WO2012175797A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR20140048190A (ko) | 2014-04-23 |
JP2014519837A (ja) | 2014-08-21 |
EP2723853B1 (fr) | 2017-12-27 |
WO2012175797A1 (fr) | 2012-12-27 |
EP2723853A1 (fr) | 2014-04-30 |
EP2723853A4 (fr) | 2015-07-22 |
US20140206029A1 (en) | 2014-07-24 |
CA2839052A1 (fr) | 2012-12-27 |
BR112013033246A2 (pt) | 2017-03-01 |
CN103814124A (zh) | 2014-05-21 |
DK2723853T3 (en) | 2018-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20115670A0 (fi) | Kardiovaskulaarinen in vitro-malli | |
BR112014005355A2 (pt) | células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença | |
GT201400162A (es) | Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas | |
AR079889A1 (es) | Antagonistas de wnt y metodos de tratamiento y deteccion | |
WO2012149299A3 (fr) | Procédés de traitement du cancer et de maladies inflammatoires au moyen de céréblon en tant que prédicteur | |
BR112013024574A2 (pt) | polipeptídeo, uso, método de tratamento de indivíduos portadores de doenças e método de tratamento de indivíduos que possuem doenças com um polipeptídeo | |
BR112014005752A2 (pt) | plataforma para tecidos e órgãos implantáveis produzidos por engenharia tecidual e métodos para sua produção | |
EP2758933A4 (fr) | Analyse clinique au moyen d'une activité électrodermique | |
EP2701700A4 (fr) | Pharmacothérapie pour empêcher des effets indésirables induits par une chimiothérapie et compositions pharmaceutiques, diagnostics, techniques de dépistage et trousses associés | |
EE05601B1 (et) | Seade ja meetod pehme bioloogilise koe mehaanilise pingeseisundi, elastsuse, dnaamilise jikuse, roomavuse ja mehaanilise pinge relaksatsiooniaega iseloomustavate parameetrite samaaegseks m??tmiseks reaalajas ning arvutiprogrammi produkt | |
EP2703481A4 (fr) | Adipocytes bruns dérivés de cellules souches pluripotentes, agrégat cellulaire dérivé de cellules souches pluripotentes, leur procédé de production, thérapie cellulaire et thérapie médicale associées | |
ECSP14002542A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
EA201591742A1 (ru) | Способ улучшения диагностики заболеваний с использованием измеряемых аналитов | |
WO2013184193A3 (fr) | Cellules souches cancéreuses et procédés d'utilisation associés | |
EP2894219A4 (fr) | Tissu cutané artificiel, modèle de peau artificielle et leur procédé de fabrication | |
BR112014007007A2 (pt) | método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico | |
WO2014140362A3 (fr) | Biomarqueurs lymphocytaires destinés à déterminer la réponse clinique à une thérapie cellulaire | |
EP2772760A4 (fr) | Procédé de mesure d'une substance physiologiquement active d'origine biologique, et microparticules et extrait pour l'utilisation dans ledit procédé | |
EP2610337A4 (fr) | Test de masse de cellules sanguines dérivées de sang humain utilisant la coagulation des cellules, cellules souches sanguines adultes utilisant ledit test, procédé d'expansion des cellules progénitrices et cellules souches produites en utilisant le procédé | |
BR112014010166A8 (pt) | uso de uma composição para a fabricação de um produto para melhorar a pontuação na bateria de testes neuropsicológicos, método para avaliar a cognição de um indivíduo e uso de uma composição para a fabricação de um produto para tratar um indivíduo em necessidade da mesma | |
EP2566879A4 (fr) | Procédé de fonctionnalisation de globules rouges humains à l'aide d'anticorps | |
FR2962443B1 (fr) | Modele de tissu adipeux et procede de preparation | |
EA201301080A1 (ru) | Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания | |
EP2903507A4 (fr) | Mesure électromécanique de l'activité des muscles/tendons stapédiens | |
RU2012118140A (ru) | Способ индивидуального назначения системной пульс-терапии глюкокортикостероидами пациентам с эндокринной офтальмопатией |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |